Advance your Cell Engineering Journey with MaxCyte®
SciMed (Asia) Pte Ltd is now the official distributor of MaxCyte’s electroporation systems in Singapore, bringing advanced non-viral transfection technology closer to your lab.
MaxCyte’s Flow Electroporation® platform enables high-efficiency, gentle delivery of a wide range of molecules—including mRNA, plasmid DNA, proteins, and CRISPR/Cas9 complexes while maintaining exceptional cell viability and reproducibility. This is made possible by its proprietary flow electroporation process, which uniformly treats cells, minimizes stress, and maximizes recovery.
With MaxCyte, you can:
- Transfect hard-to-engineer cells across a broad spectrum of cell types including primary cells, stem cells and immune cells with minimal optimization
- Scale seamlessly from early research to cGMP manufacturing
- Support workflows across drug discovery, cell and gene therapy, and protein production
If you’re looking to accelerate your work in transient transfection, stable cell line development, or genome editing, we are here to support your research needs from start to finish.
Product Details : https://staging.scimed.phchd.com/brand/maxcyte/